Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,828 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Human-multimodal deep learning collaboration in 'precise' diagnosis of lupus erythematosus subtypes and similar skin diseases.
Li Q, Yang Z, Chen K, Zhao M, Long H, Deng Y, Hu H, Jia C, Wu M, Zhao Z, Zhu H, Zhou S, Zhao M, Cao P, Zhou S, Song Y, Tang G, Liu J, Jiang J, Liao W, Zhou W, Yang B, Xiong F, Zhang S, Gao X, Jiang Y, Zhang W, Zhang B, He YL, Ran L, Zhang C, Wu W, Suolang Q, Luo H, Kang X, Wu C, Jin H, Chen L, Guo Q, Gui G, Li S, Si H, Guo S, Liu HY, Liu X, Ma GZ, Deng D, Yuan L, Lu J, Zeng J, Jiang X, Lyu X, Chen L, Hu B, Tao J, Liu Y, Wang G, Zhu G, Yao Z, Xu Q, Yang B, Wang Y, Ding Y, Yang X, Kai H, Wu H, Lu Q. Li Q, et al. Among authors: guo q, guo s. J Eur Acad Dermatol Venereol. 2024 Dec;38(12):2268-2279. doi: 10.1111/jdv.20031. Epub 2024 Apr 15. J Eur Acad Dermatol Venereol. 2024. PMID: 38619440
Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia.
Wang A, Li H, Xie Z, Li L, Jiang X, Guo Q, Hu F, Zhang J, Cui Y, Ding Y, Fang H, Han X, Guo S, Wang J, Ni N. Wang A, et al. Among authors: guo q, guo s. Dermatol Ther (Heidelb). 2023 Jul;13(7):1477-1487. doi: 10.1007/s13555-023-00938-8. Epub 2023 Jun 2. Dermatol Ther (Heidelb). 2023. PMID: 37268784 Free PMC article.
Tildrakizumab for moderate-to-severe plaque psoriasis in Chinese patients: A 12-week randomized placebo-controlled phase III trial with long-term extension.
Yu C, Geng S, Yang B, Deng Y, Li F, Kang X, Bi M, Zhang F, Zhao Y, Pan W, Tian Z, Xu J, Zhang Z, Yu N, Duan X, Guo S, Sun Q, Li W, Tao J, Liu Z, Yin Y, Wang G. Yu C, et al. Among authors: guo s. Chin Med J (Engl). 2024 May 20;137(10):1190-1198. doi: 10.1097/CM9.0000000000002873. Epub 2024 Jan 9. Chin Med J (Engl). 2024. PMID: 38192233 Free PMC article. Clinical Trial.
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients.
Li Q, Jia C, Pan W, Liu H, Tang C, Weber D, Chen K, Long H, Byrne-Steele ML, Han J, He N, Xiao R, Zhao M, Che N, Guo Q, Gui G, Li S, Si H, Guo S, Liu H, Wang G, Zhu G, Yang B, Wang Y, Ding Y, Yang X, Akihiko Y, Lu L, Chang C, Chan V, Lau CS, Qi H, Liu W, Li S, Wu H, Lu Q. Li Q, et al. Among authors: guo q, guo s. J Autoimmun. 2024 Jun;146:103203. doi: 10.1016/j.jaut.2024.103203. Epub 2024 Apr 20. J Autoimmun. 2024. PMID: 38643729 Free article.
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in patients from China mainland, Taiwan, and South Korea with moderate to severe plaque psoriasis: a phase 3 randomized clinical trial.
Zhang J, Ding Y, Wang P, Li L, Pan W, Lu Y, Cheng H, Jiang X, Ho JC, Guo S, Liu L, Chatterjee A, Kisa RM, Banerjee S. Zhang J, et al. Among authors: guo s. Br J Dermatol. 2024 Oct 22:ljae406. doi: 10.1093/bjd/ljae406. Online ahead of print. Br J Dermatol. 2024. PMID: 39437312
15,828 results
You have reached the last available page of results. Please see the User Guide for more information.